The COVID-19 mRNA vaccines elicit a strong immune response with increased plasma IgA, IgM, and IgG activity and monoclonal antibodies against SARS-CoV-2 spike protein and the receptor-binding domain (10). Here, CD79A is linked to COVID-19.